Forbion Growth Opportunities Fund I Cooperatief U.A.

Insider

FundBuying only

First filing: 2024
Latest filing: Nov 1, 2024
Filings: 2

More research on Forbion Growth Opportunities Fund I Cooperatief U.A.

The 7-day demo adds the profile details we hold on Forbion Growth Opportunities Fund I Cooperatief U.A., like a biography or board seats where we have them, and how the stock moved after past purchases where there are enough to measure. Sign-up brings you back to this page.

Start 7-day demo Sign inCard required. Your card is never charged for the demo.

Career & filing history

Every role Forbion Growth Opportunities Fund I Cooperatief U.A. has reported on a Form 4, taken from the filings. Each Form 4 states the filer's relationship to the issuer: an officer title, a director seat or 10% ownership.

Insider
at enGene Therapeutics Inc. (ENGN)
2 filings, 2024

Companies on record

1

enGene Therapeutics Inc. (ENGN)2 filings
last Nov 1, 2024

Filings (90d)

0

0 companies

Purchases

14

$8.01M

Sales

0

Summary

Latest filing: Nov 1, 2024

Forbion Growth Opportunities Fund I Cooperatief U.A. files SEC Form 4 reports at enGene Therapeutics Inc. (ENGN). 2 SEC Form 4 filings on record, most recently on 1 November 2024. Most recent open-market trade: bought $5.00M of ENGN on 1 November 2024. Lifetime open-market purchases: $8.01M.

Recent transactions

14

The latest 14 SEC Form 4 transactions reported by Forbion Growth Opportunities Fund I Cooperatief U.A..

All14Buys14

$ENGN enGene Therapeutics Inc.
Nov 1, 2024
P - Open-market purchase
561.8K shares @ $8.90$5.00M

Trading pattern

InsiderAlpha's records for Forbion Growth Opportunities Fund I Cooperatief U.A. go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $572K (14 buys totaling $8.01M). The largest single buy on record is $5.00M of ENGN in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.

Other insiders active in the same stocks

Insiders who reported open-market trades in the last 12 months at the companies Forbion Growth Opportunities Fund I Cooperatief U.A. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.

William Grossman - $10K in ENGN purchases and sales in the last 12 months

More insiders (A-Z)

Browse nearby insider profiles in alphabetical order.

Frequently asked questions

What is Forbion Growth Opportunities Fund I Cooperatief U.A.?

Forbion Growth Opportunities Fund I Cooperatief U.A. is an investment firm of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.

When did Forbion Growth Opportunities Fund I Cooperatief U.A. last file a Form 4?

The most recent primary Form 4 on record is dated 1 November 2024, one of 2 filings going back to 2024.

Has Forbion Growth Opportunities Fund I Cooperatief U.A. been buying or selling stock?

Recorded transactions: 14 open-market purchases ($8.01M) and 0 open-market sales across all tracked filings.